Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 5
2014 3
2017 1
2018 3
2019 2
2020 3
2021 3
2022 6
2023 16
2024 14
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
Karakasis P, Patoulias D, Pamporis K, Stachteas P, Bougioukas KI, Klisic A, Fragakis N, Rizzo M. Karakasis P, et al. Among authors: bougioukas ki. Metabolism. 2023 Dec;149:155710. doi: 10.1016/j.metabol.2023.155710. Epub 2023 Oct 16. Metabolism. 2023. PMID: 37852529
Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, Brennan SE, Li T, Pollock M, Lunny C, Sepúlveda D, McKenzie JE, Scott SD, Robinson KA, Matthias K, Bougioukas KI, Fusar-Poli P, Whiting P, Moss SJ, Hartling L. Gates M, et al. Among authors: bougioukas ki. BMJ. 2022 Aug 9;378:e070849. doi: 10.1136/bmj-2022-070849. BMJ. 2022. PMID: 35944924 Free PMC article.
Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias' treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis.
Pamporis K, Karakasis P, Simantiris S, Sagris M, Bougioukas KI, Fragakis N, Tousoulis D. Pamporis K, et al. Among authors: bougioukas ki. Clin Investig Arterioscler. 2024 Mar-Apr;36(2):86-100. doi: 10.1016/j.arteri.2023.11.003. Epub 2023 Nov 30. Clin Investig Arterioscler. 2024. PMID: 38040529 Review. English, Spanish.
Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials.
Pamporis K, Karakasis P, Sagris M, Zarifis I, Bougioukas KI, Pagkalidou E, Milaras N, Samaras A, Theofilis P, Fragakis N, Tousoulis D, Xanthos T, Giannakoulas G. Pamporis K, et al. Among authors: bougioukas ki. Curr Probl Cardiol. 2024 Jul;49(7):102615. doi: 10.1016/j.cpcardiol.2024.102615. Epub 2024 Apr 29. Curr Probl Cardiol. 2024. PMID: 38692445 Review.
Straatsma Syndrome: A Case Series.
Karakosta C, Paraskevopoulos K, Bisoukis A, Bougioukas K, Kokolaki A. Karakosta C, et al. Among authors: bougioukas k. Cureus. 2022 Sep 30;14(9):e29779. doi: 10.7759/cureus.29779. eCollection 2022 Sep. Cureus. 2022. PMID: 36340550 Free PMC article.
Gene promoter methylation and cancer: An umbrella review.
Bouras E, Karakioulaki M, Bougioukas KI, Aivaliotis M, Tzimagiorgis G, Chourdakis M. Bouras E, et al. Among authors: bougioukas ki. Gene. 2019 Aug 20;710:333-340. doi: 10.1016/j.gene.2019.06.023. Epub 2019 Jun 13. Gene. 2019. PMID: 31202904
44 results